Update on the clinical utility of fenofibrate in mixed dyslipidemias: mechanisms of action and rational prescribing

Michel FarnierPoint Médical, Dijon, FranceAbstract: Mixed dyslipidemia is a common lipid disorder characterized by the presence of an atherogenic lipoprotein phenotype due to abnormalities in various atherogenic and antiatherogenic lipoproteins. Despite the link between the decrease of LD...

Full description

Bibliographic Details

Published in:	Vascular Health and Risk Management
Main Author:	Michel Farnier
Format:	Article
Language:	English
Published:	Dove Medical Press 2008-10-01
Subjects:	Fenofibrate mixed dyslipidemia triglycerides LDL-cholesterol HDL-cholesterol
Online Access:	https://www.dovepress.com/update-on-the-clinical-utility-of-fenofibrate-in-mixed-dyslipidemias-m-peer-reviewed-article-VHRM